{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:38:48Z","timestamp":1790293128061,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.parkreldis.2016.03.002","type":"journal-article","created":{"date-parts":[[2016,3,5]],"date-time":"2016-03-05T15:15:54Z","timestamp":1457190954000},"page":"25-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"special_numbering":"C","title":["Pharmacological interventions for daytime sleepiness and sleep disorders in Parkinson's disease: Systematic review and meta-analysis"],"prefix":"10.1016","volume":"27","author":[{"given":"Tiago Martins","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Castro Caldas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim J.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.parkreldis.2016.03.002_bib1","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJM2003ra020003","article-title":"Alzheimer's disease and Parkinson's disease","volume":"348","author":"Nussbaum","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.03.002_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/mds.10305","article-title":"Systematic review of incidence studies of Parkinson's disease","volume":"18","author":"Twelves","year":"2003","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.parkreldis.2016.03.002_bib3","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/aje\/kwg068","article-title":"Incidence of Parkinson's disease: variation by age, gender, and race\/ethnicity","volume":"157","author":"Van Den Eeden","year":"2003","journal-title":"Am. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.parkreldis.2016.03.002_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson's disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.parkreldis.2016.03.002_bib5","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"Lancet Neurol."},{"issue":"8 Suppl 3","key":"10.1016\/j.parkreldis.2016.03.002_bib6","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1212\/WNL.63.8_suppl_3.S2","article-title":"The two faces of Eve: dopamine's modulation of wakefulness and sleep","volume":"63","author":"Rye","year":"2004","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.parkreldis.2016.03.002_bib7","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mds.22643","article-title":"The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease","volume":"24","author":"Barone","year":"2009","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.parkreldis.2016.03.002_bib8","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/00002826-198812000-00004","article-title":"The nighttime problems of Parkinson's disease","volume":"11","author":"Lees","year":"1988","journal-title":"Clin. Neuropharmacol."},{"issue":"3","key":"10.1016\/j.parkreldis.2016.03.002_bib9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1468-1331.2006.01262.x","article-title":"Sleep disruption, daytime somnolence and \u201csleep attacks\u201d in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteers","volume":"13","author":"Ferreira","year":"2006","journal-title":"Eur. J. Neurol."},{"issue":"4","key":"10.1016\/j.parkreldis.2016.03.002_bib10","doi-asserted-by":"crossref","first-page":"456","DOI":"10.7326\/0003-4819-83-4-456","article-title":"Five years' treatment of Parkinson's disease with levodopa. Therapeutic results and survival of 100 patients","volume":"83","author":"Sweet","year":"1975","journal-title":"Ann. Intern. Med."},{"issue":"9 Pt 1","key":"10.1016\/j.parkreldis.2016.03.002_bib11","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/WNL.29.9_Part_1.1253","article-title":"Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy","volume":"29","author":"Lesser","year":"1979","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.parkreldis.2016.03.002_bib12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00002826-198205020-00003","article-title":"Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis","volume":"5","author":"Nausieda","year":"1982","journal-title":"Clin. Neuropharmacol."},{"issue":"6","key":"10.1016\/j.parkreldis.2016.03.002_bib13","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/mds.870130606","article-title":"A\u00a0community-based study of sleep disorders in patients with Parkinson's disease","volume":"13","author":"Tandberg","year":"1998","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.parkreldis.2016.03.002_bib14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11910-996-0041-8","article-title":"Excessive daytime sleepiness and unintended sleep in Parkinson's disease","volume":"6","author":"Rye","year":"2006","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.parkreldis.2016.03.002_bib15","unstructured":"(NICE) TNI for CE. Parkinson's disease diagnosis and management in primary and secondary care. Clin. Guidel. 35. https:\/\/www.nice.org.uk\/guidance\/cg35."},{"issue":"11","key":"10.1016\/j.parkreldis.2016.03.002_bib16","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1212\/WNL.0b013e3181d55f24","article-title":"Quality Subcommitee of the American Academy of Neurology, Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"274","author":"Zesiewicz","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2016.03.002_bib17","series-title":"Cochrane handbook for Systematic Reviews of Interventions, Version 5.1.0","year":"2011"},{"issue":"12","key":"10.1016\/j.parkreldis.2016.03.002_bib18","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/jnnp.2005.065870","article-title":"Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial","volume":"76","author":"Ondo","year":"2005","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.parkreldis.2016.03.002_bib19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/mds.10390","article-title":"Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease","volume":"18","author":"Adler","year":"2003","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.parkreldis.2016.03.002_bib20","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/sleep\/25.8.62","article-title":"Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial","volume":"25","author":"Hogl","year":"2002","journal-title":"Sleep"},{"issue":"7","key":"10.1016\/j.parkreldis.2016.03.002_bib21","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1212\/WNL.0b013e318263570d","article-title":"Caffeine for treatment of Parkinson disease: a randomized controlled trial","volume":"79","author":"Postuma","year":"2012","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.parkreldis.2016.03.002_bib22","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1212\/01.WNL.0000158652.74601.48","article-title":"Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy","volume":"64","author":"Comella","year":"2005","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.parkreldis.2016.03.002_bib23","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.sleep.2005.04.004","article-title":"Melatonin for sleep disturbances in Parkinson's disease","volume":"6","author":"Dowling","year":"2005","journal-title":"Sleep. Med."},{"issue":"11","key":"10.1016\/j.parkreldis.2016.03.002_bib24","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1002\/mds.23168","article-title":"Treatment of insomnia in Parkinson's disease: a controlled trial of eszopiclone and placebo","volume":"25","author":"Menza","year":"2010","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.parkreldis.2016.03.002_bib25","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.parkreldis.2013.03.003","article-title":"Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson's disease \u2013 a randomized study","volume":"19","author":"Rios Romenets","year":"2013","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2016.03.002_bib26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1749-8546-8-14","article-title":"Therapeutic effect of Yang-Xue-Qing-Nao granules on sleep dysfunction in Parkinson's disease","volume":"8","author":"Pan","year":"2013","journal-title":"Chin. Med."},{"issue":"4","key":"10.1016\/j.parkreldis.2016.03.002_bib27","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/mds.24909","article-title":"Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease","volume":"27","author":"Di Giacopo","year":"2012","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.parkreldis.2016.03.002_bib28","first-page":"25","article-title":"Eyes wide shut. The dangers of sleepy driving","volume":"83","author":"Mahowald","year":"2000","journal-title":"Minn. Med."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.03.002_bib29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0001-4575(00)00013-0","article-title":"The role of driver sleepiness in car crashes: a systematic review of epidemiological studies","volume":"33","author":"Connor","year":"2001","journal-title":"Accid. Anal. Prev."},{"issue":"4","key":"10.1016\/j.parkreldis.2016.03.002_bib30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1017\/S0317167100043419","article-title":"Life effects of narcolepsy in 180 patients from North America, Asia and Europe compared to matched controls","volume":"8","author":"Broughton","year":"1981","journal-title":"Can. J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.03.002_bib31","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00006842-200101000-00006","article-title":"SF-36: evaluation of quality of life in severe and mild insomniacs compared with good sleepers","volume":"63","author":"Leger","year":"2001","journal-title":"Psychosom. Med."},{"issue":"Suppl 2","key":"10.1016\/j.parkreldis.2016.03.002_bib32","first-page":"S379","article-title":"Quality of life in people with insomnia","volume":"22","author":"Zammit","year":"1999","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.parkreldis.2016.03.002_bib33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.parkreldis.2003.11.002","article-title":"Nocturnal sleep disturbances and daytime dysfunction in patients with Parkinson's disease and in their caregivers","volume":"10","author":"Pal","year":"2004","journal-title":"Park. Relat. Disord."},{"issue":"2","key":"10.1016\/j.parkreldis.2016.03.002_bib34","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1532-5415.1997.tb04506.x","article-title":"Sleep disturbances in Parkinson's disease patients and spouses","volume":"45","author":"Smith","year":"1997","journal-title":"J.\u00a0Am. Geriatr. Soc."},{"issue":"8","key":"10.1016\/j.parkreldis.2016.03.002_bib35","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/sleep\/30.8.959","article-title":"Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations","volume":"30","author":"Walsh","year":"2007","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.parkreldis.2016.03.002_bib36","first-page":"63","article-title":"Treating the health, quality of life, and functional impairments in insomnia","volume":"3","author":"Krystal","year":"2007","journal-title":"J.\u00a0Clin. Sleep. Med."},{"issue":"14","key":"10.1016\/j.parkreldis.2016.03.002_bib37","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1212\/01.wnl.0000258660.74391.c1","article-title":"EASE-PD Adjunct Study Investigators, Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease","volume":"68","author":"Pahwa","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.parkreldis.2016.03.002_bib38","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/mds.23441","article-title":"Recover Study Group, Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER)","volume":"26","author":"Trenkwalder","year":"2011","journal-title":"Mov. Disord."},{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2016.03.002_bib39","first-page":"S15","article-title":"Sleep disorders in Parkinson's disease","volume":"245","author":"Stocchi","year":"1998","journal-title":"J.\u00a0Neurol."},{"issue":"3","key":"10.1016\/j.parkreldis.2016.03.002_bib40","first-page":"235","article-title":"International (NL-UK) double-blind study of Sinemet CR and standard Sinemet (25\/100) in 170 patients with fluctuating Parkinson's disease","volume":"243","author":"Wolters","year":"1996","journal-title":"J.\u00a0Neurol."},{"issue":"6","key":"10.1016\/j.parkreldis.2016.03.002_bib41","first-page":"498","article-title":"A\u00a0comparison of Madopar CR and standard Madopar in the treatment of nocturnal and early-morning disability in Parkinson's disease. The U.K. Madopar CR Study Group","volume":"12","year":"1989","journal-title":"Clin. Neuropharmacol."},{"issue":"13","key":"10.1016\/j.parkreldis.2016.03.002_bib42","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1517\/14656566.2011.604031","article-title":"Effect of rotigotine on sleep and quality of life in Parkinson's disease patients: post hoc analysis of RECOVER patients who were symptomatic at baseline","volume":"12","author":"Ghys","year":"2011","journal-title":"Expert Opin. Pharmacother."},{"issue":"12","key":"10.1016\/j.parkreldis.2016.03.002_bib43","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00702-010-0506-4","article-title":"Rotigotine transdermal system for control of early morning motor impairment and sleep disturbances in patients with Parkinson's disease","volume":"117","author":"Giladi","year":"2010","journal-title":"J.\u00a0Neural Transm."},{"issue":"6","key":"10.1016\/j.parkreldis.2016.03.002_bib44","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S1474-4422(07)70108-4","article-title":"SP 515 Investigators, Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial","volume":"6","author":"Poewe","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2016.03.002_bib45","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2377-13-113","article-title":"Comparison of once-daily versus twice-daily combination of ropinirole prolonged release in Parkinson's disease","volume":"13","author":"Yun","year":"2013","journal-title":"BMC Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.03.002_bib46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1468-1331.2011.03442.x","article-title":"Improvements in nocturnal symptoms with ropinirole prolonged release in patients with advanced Parkinson's disease","volume":"19","author":"Ray Chaudhuri","year":"2012","journal-title":"Eur. J. Neurol."},{"issue":"5","key":"10.1016\/j.parkreldis.2016.03.002_bib47","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/WNF.0b013e31815d25ce","article-title":"Effects of ropinirole on nonmotor symptoms of Parkinson disease: a prospective multicenter study","volume":"31","author":"Rektorova","year":"2008","journal-title":"Clin. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.03.002_bib48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/mds.23396","article-title":"Twice-daily, low-dose pramipexole in early Parkinson's disease: a randomized, placebo-controlled trial","volume":"26","author":"Kieburtz","year":"2011","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.parkreldis.2016.03.002_bib49","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1016\/j.archger.2010.03.008","article-title":"Tolcapone improves sleep in patients with advanced Parkinson's disease (PD)","volume":"51","author":"Ebersbach","year":"2010","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"3","key":"10.1016\/j.parkreldis.2016.03.002_bib50","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/mds.870130302","article-title":"Clozapine use in Parkinson's disease: a retrospective analysis of a large multicentered clinical experience","volume":"13","author":"Trosch","year":"1998","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.parkreldis.2016.03.002_bib51","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/mds.21116","article-title":"Effect of quetiapine in psychotic Parkinson's disease patients: a double-blind labeled study of 3 months' duration","volume":"22","author":"Rabey","year":"2007","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.parkreldis.2016.03.002_bib52","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1212\/01.wnl.0000168864.97813.e0","article-title":"Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD","volume":"65","author":"Iranzo","year":"2005","journal-title":"Neurology"},{"issue":"9916","key":"10.1016\/j.parkreldis.2016.03.002_bib53","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(13)62106-6","article-title":"Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial","volume":"383","author":"Cummings","year":"2014","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.parkreldis.2016.03.002_bib54","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1212\/01.wnl.0000336340.89821.b3","article-title":"A\u00a0controlled trial of antidepressants in patients with Parkinson disease and depression","volume":"72","author":"Menza","year":"2009","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.parkreldis.2016.03.002_bib55","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1212\/WNL.0b013e3181ebdd79","article-title":"Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease","volume":"75","author":"Weintraub","year":"2010","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.parkreldis.2016.03.002_bib56","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.parkreldis.2010.12.003","article-title":"Memantine for non-motor features of Parkinson's disease: a double-blind placebo controlled exploratory pilot trial","volume":"17","author":"Ondo","year":"2011","journal-title":"Park. Relat. Disord."},{"issue":"Suppl 3","key":"10.1016\/j.parkreldis.2016.03.002_bib57","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1002\/mds.23884","article-title":"The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease","volume":"26","author":"Seppi","year":"2011","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.03.002_bib58","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1468-1331.2012.03866.x","article-title":"Summary of the recommendations of the EFNS\/MDS-ES review on therapeutic management of Parkinson's disease","volume":"20","author":"Ferreira","year":"2013","journal-title":"Eur. J. Neurol."},{"issue":"12","key":"10.1016\/j.parkreldis.2016.03.002_bib59","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/sleep\/30.12.1705","article-title":"Standards of Practice Committee of the American Academy of Sleep Medicine, Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin","volume":"30","author":"Morgenthaler","year":"2007","journal-title":"Sleep"},{"issue":"5","key":"10.1016\/j.parkreldis.2016.03.002_bib60","doi-asserted-by":"crossref","first-page":"487","DOI":"10.5664\/jcsm.27286","article-title":"Clinical guideline for the evaluation and management of chronic insomnia in adults","volume":"4","author":"Schutte-Rodin","year":"2008","journal-title":"J.\u00a0Clin. Sleep. Med."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.03.002_bib61","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5664\/jcsm.27717","article-title":"Best practice guide for the treatment of REM sleep behavior disorder (RBD)","volume":"6","author":"Aurora","year":"2010","journal-title":"J.\u00a0Clin. Sleep. Med."},{"issue":"8","key":"10.1016\/j.parkreldis.2016.03.002_bib62","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.5665\/sleep.1986","article-title":"The treatment of restless legs syndrome and periodic limb movement disorder in adults\u2013an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline","volume":"35","author":"Aurora","year":"2012","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.parkreldis.2016.03.002_bib63","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ana.21631","article-title":"Selective enhancement of rapid eye movement sleep by deep brain stimulation of the human pons","volume":"66","author":"Lim","year":"2009","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.parkreldis.2016.03.002_bib64","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/mds.22496","article-title":"Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease","volume":"24","author":"Volkmann","year":"2009","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.parkreldis.2016.03.002_bib65","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.sleep.2010.05.003","article-title":"Double-blind, randomized, placebo controlled trial on the effect of 10 days low-frequency rTMS over the vertex on sleep in Parkinson's disease","volume":"11","author":"Arias","year":"2010","journal-title":"Sleep. Med."},{"issue":"Suppl.\u00a02","key":"10.1016\/j.parkreldis.2016.03.002_bib66","first-page":"S132","article-title":"High frequency repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's disease: A randomized, double-blind, placebo-controlled study","volume":"26","author":"Kovacs","year":"2011","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.parkreldis.2016.03.002_bib67","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/gps.2472","article-title":"A\u00a0pilot randomized controlled trial of sleep therapy in Parkinson's disease: effect on patients and caregivers","volume":"25","author":"Leroi","year":"2010","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"3","key":"10.1016\/j.parkreldis.2016.03.002_bib68","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/07420520701420717","article-title":"Primary and secondary features of Parkinson's disease improve with strategic exposure to bright light: a case series study","volume":"24","author":"Willis","year":"2007","journal-title":"Chronobiol. Int."},{"issue":"10","key":"10.1016\/j.parkreldis.2016.03.002_bib69","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/mds.21542","article-title":"Bright light therapy in Parkinson's disease: a pilot study","volume":"22","author":"Paus","year":"2007","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.parkreldis.2016.03.002_bib70","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.eujim.2012.10.005","article-title":"\u201cEffects of Tactile Touch on pain, sleep and health related quality of life in Parkinson's disease with chronic pain\u201d: A randomized, controlled and prospective study","volume":"5","author":"Skogar","year":"2013","journal-title":"Eur. J. Integr. Med."},{"issue":"1","key":"10.1016\/j.parkreldis.2016.03.002_bib71","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5665\/sleep.3332","article-title":"Continuous positive airway pressure improves sleep and daytime sleepiness in patients with Parkinson disease and sleep apnea","volume":"37","author":"Neikrug","year":"2014","journal-title":"Sleep"},{"key":"10.1016\/j.parkreldis.2016.03.002_bib72","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1100\/tsw.2010.221","article-title":"Active theater as a complementary therapy for Parkinson's disease rehabilitation: a pilot study","volume":"10","author":"Modugno","year":"2010","journal-title":"Sci. World J."},{"key":"10.1016\/j.parkreldis.2016.03.002_bib73","doi-asserted-by":"crossref","first-page":"e5004","DOI":"10.1136\/bmj.e5004","article-title":"Physiotherapy intervention in Parkinson's disease: systematic review and meta-analysis","volume":"345","author":"Tomlinson","year":"2012","journal-title":"BMJ"},{"issue":"16","key":"10.1016\/j.parkreldis.2016.03.002_bib74","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1002\/mds.23190","article-title":"Scales to assess sleep impairment in Parkinson's disease: critique and recommendations","volume":"25","author":"Hogl","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.03.002_bib75","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802016300566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802016300566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T14:20:30Z","timestamp":1600266030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802016300566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":75,"alternative-id":["S1353802016300566"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2016.03.002","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological interventions for daytime sleepiness and sleep disorders in Parkinson's disease: Systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2016.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}